Inhibition of advanced glycation end-product formation by Origanum majorana L. in vitro and in streptozotocin-induced diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Perez Gutierrez, Rosa Martha ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN; ORIGANUM MAJORANA EXTRACT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCATION; IN VITRO STUDY; IN VIVO STUDY; MARJORAM; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

EID: 84867782934     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/598638     Document Type: Article

References (30)

1. Rahbar S., Figarola J. L., Novel inhibitors of advanced glycation endproducts. Archives of Biochemistry and Biophysics 2003 419 1 63 79 2-s2.0-0142029114 10.1016/j.abb.2003.08.009 (Pubitemid 37287559)
2. Ahmed N., Advanced glycation endproductsrole in pathology of diabetic complications. Diabetes Research and Clinical Practice 2005 67 1 3 21 2-s2.0-11144324314 10.1016/j.diabres.2004.09.004 (Pubitemid 40037725)
3. Uchiyama M., Mihara M., Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 1978 86 1 271 278 2-s2.0-0018069570 (Pubitemid 9050395)
4. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A., Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994 91 11 4766 4770 2-s2.0-0028363366 10.1073/pnas.91.11.4766 (Pubitemid 24177730)
5. Brownlee M., The pathological implications of protein glycation. Clinical and Investigative Medicine 1995 18 4 275 281 2-s2.0-0029560077 (Pubitemid 26004873)
6. Dorman H. J. D., Peltoketo A., Hiltunen R., Tikkanen M. J., Characterisation of the antioxidant properties of de-odourised aqueous extracts from selected Lamiaceae herbs. Food Chemistry 2003 83 2 255 262 2-s2.0-0041620252 10.1016/S0308-8146(03)00088-8 (Pubitemid 36962891)
7. Zheng W., Wang S. Y., Antioxidant activity and phenolic compounds in selected herbs. Journal of Agricultural and Food Chemistry 2001 49 11 5165 5170 2-s2.0-0035186746 10.1021/jf010697n (Pubitemid 33089648)
8. Jun W. J., Han B. K., Yu K. W., Kim M. S., Chang I. S., Kim H. Y., Cho H. Y., Antioxidant effects of Origanum majorana L. on superoxide anion radicals. Food Chemistry 2001 75 4 439 444 2-s2.0-0035162024 10.1016/S0308-8146(01)00233-3 (Pubitemid 33069407)
9. Handl S., Hellweg P., Khol-Parisini A., Rossmann B., Thurner K., Luf W., Novak J., Zentek J., Effect of oregano (O. majorana × O. vulgare) on performance and antioxidative capacity of quails fed a diet rich in ω 3 fatty acids. Journal of Animal Physiology and Animal Nutrition 2008 92 3 242 245 2-s2.0-43449100044 10.1111/j.1439-0396.2007.00731.x (Pubitemid 351670165)
10. Nakatani N., Phenolic antioxidants from herbs and spices. BioFactors 2000 13 14 141 146 2-s2.0-0034490947 (Pubitemid 32107358)
11. Vági E., Rapavi E., Hadolin M., Vasarhelyine Peredi K., Balázs A., Blázovics A., Simándi B., Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. Journal of Agricultural and Food Chemistry 2005 53 1 17 21 2-s2.0-11244271489 10.1021/jf048777p (Pubitemid 40066463)
12. Kawabata J., Mizuhata K., Sato E., Nishioka T., Aoyama Y., Kasai T., 6-Hydroxyflavonoids as α -glucosidase inhibitors from marjoram (Origanum majorana) leaves. Bioscience, Biotechnology and Biochemistry 2003 67 2 445 447 2-s2.0-0042127067 (Pubitemid 39252011)
13. Brownlee M., Vlassara H., Kooney A., Ulrich P., Cerami A., Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986 232 4758 1629 1632 2-s2.0-0022644227 (Pubitemid 16095602)
14. Peng X., Zheng Z., Cheng K. W., Shan F., Ren G. X., Chen F., Wang M., Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation endproducts. Food Chemistry 2008 106 2 475 481 2-s2.0-34548218221 10.1016/j.foodchem.2007.06.016 (Pubitemid 47332851)
15. Khalifah R. G., Baynes J. W., Hudson B. G., Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. Biochemical and Biophysical Research Communications 1999 257 2 251 258 2-s2.0-0033551042 10.1006/bbrc.1999.0371 (Pubitemid 29301430)
16. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
17. Jain S. K., Palmer M., The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radical Biology and Medicine 1997 22 4 593 596 2-s2.0-0031029953 10.1016/S0891-5849(96)00377-2 (Pubitemid 27043396)
18. Esterbauer H., Striegl G., Phul H., Rotheneder M., Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989 6 1 67 75 2-s2.0-0024550456 (Pubitemid 19109796)
19. Li D., Devaraj S., Fuller C., Bucala R., Jialal I., Effect of α -tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. Journal of Lipid Research 1996 37 9 1978 1986 2-s2.0-0029792866 (Pubitemid 26307679)
20. Duell P. B., Oram J. F., Bierman E. L., Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 1990 39 10 1257 1263 2-s2.0-0025038731 (Pubitemid 20327063)
21. McFarland K. F., Catalano E. W., Day J. F., Thorpe S. R., Baynes J. W., Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 1979 28 11 1011 1014 2-s2.0-0018598262 (Pubitemid 10198195)
22. Nakayama H., Mitsuhashi T., Kuwajima S., Aoki S., Kuroda Y., Itoh T., Nakagawa S., Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes 1993 42 2 345 350 2-s2.0-0027464866 (Pubitemid 23045041)
23. Jung K., Pergande M., Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. Federation of European Biochemical Societies Letters 1985 183 1 167 169 2-s2.0-0021992163 10.1016/0014-5793(85)80977-7 (Pubitemid 15097520)
24. Mihara M., Uchiyama M., Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 1978 86 1 271 278 2-s2.0-0018069570 (Pubitemid 9050395)
25. Woessner J. F., The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Archives of Biochemistry and Biophysics 1961 93 2 440 447 2-s2.0-33745996622
26. Rao P., Pattabiraman T. N., Reevaluation of the phenol-sulfuric acid reaction for the estimation of hexoses and pentoses. Analytical Biochemistry 1989 181 1 18 22 2-s2.0-0024370514 (Pubitemid 19210783)
27. Monnier V. M., Intervention against the Maillard reaction in vivo. Archives of Biochemistry and Biophysics 2003 419 1 1 15 2-s2.0-0142026785 10.1016/j.abb.2003.08.014 (Pubitemid 37272155)
28. Menzel E. J., Sobal G., Staudinger A., The role of oxidative stress in the long-term glycation of LDL. BioFactors 1997 6 2 111 124 2-s2.0-0030693190 (Pubitemid 27487815)
29. Venkateswaran S., Pari L., Suguna L., Chandrakasan G., Modulatory effect of Coccinia indica on aortic collagen in streptozotocin-induced diabetic rats. Clinical and Experimental Pharmacology and Physiology 2003 30 3 157 163 2-s2.0-0037347228 10.1046/j.1440-1681.2003.03812.x (Pubitemid 36343938)
30. Kuzuya M., Asai T., Kanda S., Maeda K., Cheng X. W., Iguchi A., Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice. Diabetologia 2001 44 4 433 436 2-s2.0-0035060783 10.1007/s001250051640 (Pubitemid 32324353)